208 related articles for article (PubMed ID: 28315230)
21. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
22. Gamma Knife surgery for the treatment of 5 to 15 metastases to the brain: clinical article.
Salvetti DJ; Nagaraja TG; McNeill IT; Xu Z; Sheehan J
J Neurosurg; 2013 Jun; 118(6):1250-7. PubMed ID: 23540265
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article.
Kondziolka D; Kano H; Harrison GL; Yang HC; Liew DN; Niranjan A; Brufsky AM; Flickinger JC; Lunsford LD
J Neurosurg; 2011 Mar; 114(3):792-800. PubMed ID: 20887087
[TBL] [Abstract][Full Text] [Related]
24. Multidisciplinary treatment of brain metastases derived from colorectal cancer incorporating stereotactic radiosurgery: analysis of 78 patients.
Fokas E; Henzel M; Hamm K; Surber G; Kleinert G; Engenhart-Cabillic R
Clin Colorectal Cancer; 2011 Jun; 10(2):121-5. PubMed ID: 21859565
[TBL] [Abstract][Full Text] [Related]
25. [Brain metastases from esophageal cancers: clinical features and treatment results].
Sueyama H; Yamanoi T; Uematu T; Saitou M; Sakai K; Sugita T; Tsuchida E; Matumoto Y; Sasamoto R; Ito T
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Sep; 61(10):534-9. PubMed ID: 11676170
[TBL] [Abstract][Full Text] [Related]
26. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
27. Metastasis of esophageal carcinoma to the brain.
Weinberg JS; Suki D; Hanbali F; Cohen ZR; Lenzi R; Sawaya R
Cancer; 2003 Nov; 98(9):1925-33. PubMed ID: 14584076
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases.
DiLuna ML; King JT; Knisely JP; Chiang VL
Cancer; 2007 Jan; 109(1):135-45. PubMed ID: 17133440
[TBL] [Abstract][Full Text] [Related]
30. Gamma Knife surgery for brain metastases from gastrointestinal cancer.
Da Silva AN; Nagayama K; Schlesinger DJ; Sheehan JP
J Neurosurg; 2009 Sep; 111(3):423-30. PubMed ID: 19722810
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer brain metastases - A 12 year review of treatment outcomes.
De Ieso PB; Schick U; Rosenfelder N; Mohammed K; Ross GM
Breast; 2015 Aug; 24(4):426-33. PubMed ID: 25881974
[TBL] [Abstract][Full Text] [Related]
32. Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy?
Rice TW; Khuntia D; Rybicki LA; Adelstein DJ; Vogelbaum MA; Mason DP; Murthy SC; Blackstone EH
Ann Thorac Surg; 2006 Dec; 82(6):2042-9, 2049.e1-2. PubMed ID: 17126108
[TBL] [Abstract][Full Text] [Related]
33. Management of brain metastases from non-small cell lung cancer.
Baykara M; Kurt G; Buyukberber S; Demirci U; Ceviker N; Algin E; Coskun U; Aykol S; Emmez H; Ozet A; Benekli M
J Cancer Res Ther; 2014; 10(4):915-21. PubMed ID: 25579528
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer metastatic to the brain: time trends in presentation and outcome.
Nieder C; Pawinski A; Balteskard L
Oncology; 2009; 76(5):369-74. PubMed ID: 19321946
[TBL] [Abstract][Full Text] [Related]
35. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
37. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgery.
Grubb CS; Jani A; Wu CC; Saad S; Qureshi YH; Nanda T; Yaeh A; Rozenblat T; Sisti MB; Bruce JN; McKhann GM; Sheth SA; Lesser J; Cheng SK; Isaacson SR; Lassman AB; Connolly EP; Wang TJ
J Neurooncol; 2016 Mar; 127(1):103-10. PubMed ID: 26615564
[TBL] [Abstract][Full Text] [Related]
39. Patients with brain metastases derived from gastrointestinal cancer: clinical characteristics and prognostic factors.
Lin L; Zhao CH; Ge FJ; Wang Y; Chen YL; Liu RR; Jia R; Liu LJ; Liu JZ; Xu JM
Clin Transl Oncol; 2016 Jan; 18(1):93-8. PubMed ID: 26193984
[TBL] [Abstract][Full Text] [Related]
40. Survival and prognostic factors in patients with brain metastases from malignant melanoma.
Meier S; Baumert BG; Maier T; Wellis G; Burg G; Seifert B; Dummer R
Onkologie; 2004 Apr; 27(2):145-9. PubMed ID: 15138346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
